Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 replaces the previous Revision: v3.3.3 on the page header/footer. This appears to be a minor system update and does not affect trial details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page footer now shows a new revision label Revision: v3.3.3. The items HHS Vulnerability Disclosure and the previous Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted'. This signals that the trial's results have been submitted for posting or review.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page shows a new site revision label 'Revision: v3.3.2' and removal of 'Revision: v3.2.0', a routine maintenance/version-tracking change with no impact on study data, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding/operating status notice was removed from the page. This change does not affect the study details, eligibility criteria, or contacts.SummaryDifference0.4%

- Check76 days agoChange DetectedMinor administrative edits and timestamp updates with no changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.